World's Best Scientists 2026 revealed!
Tibor Diamantstein

Tibor Diamantstein

D-Index & Metrics

Immunology

D-Index
50
Citations
7120
World Ranking
4282
National Ranking
285

Tibor Diamantstein publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tibor Diamantstein sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 202 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tibor Diamantstein D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tibor Diamantstein sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Tibor Diamantstein was affiliated with Freie Universität Berlin in Germany during their academic career. The scientist's work and contributions to the research community are recorded primarily through their association with this institution.

There is no available record of recent papers, co-authors, publication venues, or book publications attributed to Tibor Diamantstein. Similarly, detailed information on their main fields of study, subfields, or specific research topics is not present in the accessible data.

Likewise, no awards or honors have been documented in connection with their academic profile. While the absence of detailed bibliometric or topical information limits a thorough review of their scientific focus, it reflects a lack of publicly available data rather than the scope of their career.

Due to the lack of specific research outputs, collaborative networks, or publication data in this profile, only their institutional affiliation and the confirmation of their passing can be reported.

Best Publications

  • Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

    Thomas Blankenstein;Zheng Hong Qin;K Uberla;Werner Muller

  • Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

    H Hock;M Dorsch;T Diamantstein;T Blankenstein

  • Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

    Hanno Hock;Marion Dorsch;Ulrich Kunzendorf;Zhihai Qin

  • Interleukin 10 Transfected into Chinese Hamster Ovary Cells Prevents Tumor Growth and Macrophage Infiltration

    Günther Richter;Sabine Krüger-Krasagakes;Gabriela Hein;Christoph Hüls

  • Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay.

    Olivera Josimovic-Alasevic;Horst Dürkop;Roland Schwarting;Eva Backé

  • Expression of interleukin 10 in human melanoma.

    S Krüger-Krasagakes;K Krasagakis;C Garbe;E Schmitt

  • B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.

    Rafael Fernandez-Botran;Peter H. Krammer;T. Diamantstein;Jonathan W. Uhr

  • Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction

    Cornelia Platzer;Günther Richter;Klaus Überla;Werner Müller

  • Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.

    Jerzy W. Kupiec-Weglinski;Tibor Diamantstein;Nicholas L. Tilney;Terry B. Strom

  • Vaccinations with Tumor Cells Genetically Engineered to Produce Different Cytokines: Effectivity not Superior to a Classical Adjuvant

    Hanno Hock;Marion Dorsch;Ulrich Kunzendorf;Klaus Überla

  • Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases

    Hans-Dieter Foss;Hermann Herbst;Elisabeth Oelmann;Jens Samol

  • Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity.

    G Yamada;Y Kitamura;H Sonoda;H Harada

  • Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation.

    Jerzy W. Kupiec-Weglinski;Tibor Diamantstein;Nicholas L. Tilney

  • Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence

    Akira Shimuzu;Shigeru Kondo;Shun Ichi Takeda;Junji Yodoi

  • The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies.

    Tibor Diamantstein;Hisao Osawa

  • Generation of competitor DNA fragments for quantitative PCR.

    K Uberla;C Platzer;T Diamantstein;T Blankenstein

  • A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody.

    Unknown

  • Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site.

    Jean‐Louis ‐L Moreau;Markus Nabholz;Tibor Diamantstein;Thomas Malek

  • Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6

    Junming Le;G. Fredrickson;L. F. L. Reis;T. Diamantstein

  • The characteristics of a monoclonal antibody that binds specifically to rat T lymphoblasts and inhibits IL 2 receptor functions.

    Unknown

  • TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.

    M Okada;M Maeda;Y Tagaya;Y Taniguchi

  • Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage.

    G. Pizzolo;F. Vinante;M. Chilosi;F. Dallenbach

  • Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. I. Target cells and possible mode of action.

    T. Diamantstein;W. Vogt;H. Rühl;Gudrun Bochert

  • Monoclonal antibody-recognizing cone visual pigment

    Unknown

  • Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis

    Z Qin;S Krüger-Krasagakes;U Kunzendorf;H Hock

Frequent Co-Authors

Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
Nicholas L. Tilney
Nicholas L. Tilney Brigham and Women's Hospital
Jerzy W. Kupiec-Weglinski
Jerzy W. Kupiec-Weglinski University of California, Los Angeles
Zhihai Qin
Zhihai Qin Chinese Academy of Sciences
Jörg Reimann
Jörg Reimann University of Ulm
Stefan H. E. Kaufmann
Stefan H. E. Kaufmann Max Planck Institute for Infection Biology
Toshimitsu Uede
Toshimitsu Uede Hokkaido University
Hans-Dieter Volk
Hans-Dieter Volk Charité - University Medicine Berlin
Silvia Bulfone-Paus
Silvia Bulfone-Paus University of Manchester
Junji Yodoi
Junji Yodoi Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary healthcare degrees can broaden career opportunities. Many students pivot towards nursing programs that integrate immunological principles and patient care.

Accelerated nursing options, such as accelerated fnp programs, offer fast-tracked routes to advanced nursing roles. These programs emphasize clinical immunology, disease prevention, and treatment, making them a practical extension for immunology graduates.

For individuals without a nursing background, online absn programs for non nurses provide flexible learning paths to become registered nurses. These programs often highlight immunological coursework relevant to patient care and research.

Understanding the accessibility of programs is also important. Identifying accelerated nursing programs can help prospective students find feasible options that align with their academic background and career goals.

Similarly, those aiming for practical roles may consider the best easiest lpn programs to get into, offering entry-level nursing credentials that often incorporate immunology fundamentals applicable in clinical settings.

Exploring these related degrees can enrich understanding and open diverse career pathways in healthcare and research fields connected to immunology.

Best Scientists Citing Tibor Diamantstein

Recently Published Articles